FDA Requests Additional Information From Makers of Asthma Drugs for Children - DJ
More News related to AZN
- Notable Analyst Rating Changes 11/09: RSH, ANF, NOC, ADBE, HERO Upgraded; RIMM, RHT, GPS, AZN, SGY Downgraded
- RBS Upgrades AstraZeneca (AZN) to Buy
- J.P. Morgan Downgrades AstraZeneca (AZN) to Underweight
- Emerging Stock Report Initiates Independent Research Coverage On Human Genome Sciences
- Widespread Generic Erosion of Atypical Antipsychotics Will Cause the Bipolar Disorder Drug Market to Decline By More Than $1 Billion Through 2018
More News related to GSK
- CORRECTING and REPLACING GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010
- Glaxo (GSK) and XenoPort (XNPT) Announed that U.S. FDA Has Extended the Review Date of GSK1838262/XP13512
- GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010
- Trading Outlook for Advanced Life Sciences Holdings Inc. Issued by InvestorSoup.com
- Antigenics (AGEN) Indicated that Glaxo's malaria Vaccine Phase III Enrolled 5000 Children to Date
More News related to NVS
- MultiVu Video Feed: BASKETBALL LEGEND KAREEM ABDUL-JABBAR ANNOUNCES HE HAS BEEN DIAGNOSED WITH CHRONIC MYELOID LEUKEMIA; AIMS TO INSPIRE OTHERS
- Novartis (NVS) Acquires Majority Stake in Zhejiang Tianyuan Bio-Pharmaceutical for $125 Million
- Emerging Stock Report Initiates Independent Research Coverage On Human Genome Sciences
- D.C. Vaccine Conference Attracts Government Policy Makers and Biotech Innovators
- Trading Outlook for Novavax Inc. Issued by InvestorSoup.com
More News related to FDA
- Teva Pharma (TEVA) Gets Final U.S. FDA Approval for Generic Prevacid
- Mylan (MYL) Gets FDA Ok for Generic Prevacid
Dow Jones reports the U.S. FDA said it's requested additional information from makers of certain asthma drugs as part of an ongoing safety review of the drugs in children.
The FDA will schedule another advisory panel later this year or early next year to evaluate any new information on the drugs, which include GlaxoSmithKline PLC's (NYSE: GSK) Serevent and Advair, Novartis AG's (NYSE: NVS) and Schering-Plough's (NYSE: SGP) Foradil and AstraZeneca's (NYSE: AZN) Symbicort.
GlaxoSmithKline plc (GSK) is a global healthcare group engaged in the creation, discovery, development, manufacture and marketing of pharmaceutical and consumer health-related products. [SM]
Related Categories
FDAStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
